Extrawell Pharmaceutical Holdings (HKSE:00858) Pre-Tax Income : HK$-151.04 Mil (TTM As of Sep. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Extrawell Pharmaceutical Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Extrawell Pharmaceutical Holdings's pretax income for the six months ended in Sep. 2023 was HK$-235.80 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-151.04 Mil. Extrawell Pharmaceutical Holdings's pretax margin was -782.31%.

During the past 13 years, Extrawell Pharmaceutical Holdings's highest Pretax Margin was 180.36%. The lowest was -220.10%. And the median was 29.41%.

Extrawell Pharmaceutical Holdings Pre-Tax Income Historical Data

The historical data trend for Extrawell Pharmaceutical Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extrawell Pharmaceutical Holdings Pre-Tax Income Chart

Extrawell Pharmaceutical Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Pre-Tax Income

Get a 7-Day Free Trial

63.37

85.49

-119.66

132.33

130.90

Extrawell Pharmaceutical Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Pre-Tax Income	Get a 7-Day Free Trial															90.63	41.70	46.15	84.75	-235.80

Competitive Comparison of Extrawell Pharmaceutical Holdings's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Extrawell Pharmaceutical Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Extrawell Pharmaceutical Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Extrawell Pharmaceutical Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Extrawell Pharmaceutical Holdings's Pre-Tax Income falls into.

Extrawell Pharmaceutical Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Extrawell Pharmaceutical Holdings's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-11.789	+	0	+	-15.636	+	2.986	+	155.34
	=	130.90

Extrawell Pharmaceutical Holdings's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-3.224	+	0	+	-9.016	+	2.87	+	-226.425
	=	-235.80

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-151.04 Mil.

Extrawell Pharmaceutical Holdings (HKSE:00858) Pre-Tax Income Explanation

Extrawell Pharmaceutical Holdings's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-235.795	/	30.141
	=	-782.31%

During the past 13 years, Extrawell Pharmaceutical Holdings's highest Pretax Margin was 180.36%. The lowest was -220.10%. And the median was 29.41%.

Extrawell Pharmaceutical Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Extrawell Pharmaceutical Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Extrawell Pharmaceutical Holdings (HKSE:00858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) » Definitions » Pre-Tax Income

Traded in Other Exchanges

N/A

Address

979 King’s Road, Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, Quarry Bay, Hong Kong, HKG

Website

http://www.extrawell.com.hk

Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.

Executives

Mao Yumin	2201 Interest of corporation controlled by you
Biowindow Gene Development (hong Kong) Limited	2201 Interest of corporation controlled by you
Ease Gold Investments Limited	2201 Interest of corporation controlled by you
Jnj Investments Ltd	2201 Interest of corporation controlled by you
United Gene Group Ltd	2201 Interest of corporation controlled by you
United Gene Holdings Limited	2201 Interest of corporation controlled by you
United Gene International Holdings Group Limited	2101 Beneficial owner
Xie Yi	2201 Interest of corporation controlled by you
Huang Zhenping	2101 Beneficial owner
United Gene Industry Group Limited	2101 Beneficial owner
Chen Xuhua	2202 Interest of your spouse
Cheng Yong	2201 Interest of corporation controlled by you

Extrawell Pharmaceutical Holdings (HKSE:00858) Headlines

No Headlines